We are live on ! Find out more
VTVT icon

vTv Therapeutics
VTVT

18 hedge funds and large institutions have $1.48M invested in vTv Therapeutics in 2019 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

43% more capital invested

Capital invested by funds: $1.04M → $1.48M (+$444K)

0.01% more ownership

Funds ownership: 0.05% → 0.06% (+0.01%)

5% less funds holding

Funds holding: 19 → 18 (-1)

17% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 6

50% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 4

Holders
18
Holders Change
-1
Holders Change %
-5.26%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
2
Reduced
4
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
+$195K
2
Barclays
Barclays
United Kingdom
+$194K
3
Two Sigma Investments
Two Sigma Investments
New York
+$134K
4
Renaissance Technologies
Renaissance Technologies
New York
+$58.7K
5
ECM
ExodusPoint Capital Management
New York
+$24.4K

Top Sellers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
-$119K
2
BCM
Bridgeway Capital Management
Texas
-$107K
3
WS
Wedbush Securities
California
-$39K
4
Goldman Sachs
Goldman Sachs
New York
-$17K
5
Millennium Management
Millennium Management
New York
-$16K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$405K – – –
Bank of America
2
Bank of America
North Carolina
$220K +$195K +3,208 +15,276%
Barclays
3
Barclays
United Kingdom
$217K +$194K +3,189 New
Geode Capital Management
4
Geode Capital Management
Massachusetts
$191K – – –
Two Sigma Investments
5
Two Sigma Investments
New York
$150K +$134K +2,208 New
BlackRock
6
BlackRock
New York
$109K -$243 -4 -0.3%
Renaissance Technologies
7
Renaissance Technologies
New York
$66K +$58.7K +967 New
D.E. Shaw & Co
8
D.E. Shaw & Co
New York
$35K -$13.5K -223 -30%
ECM
9
ExodusPoint Capital Management
New York
$27K +$24.4K +402 New
Northern Trust
10
Northern Trust
Illinois
$21K – – –
Deutsche Bank
11
Deutsche Bank
Germany
$15K +$14.1K +232 New
Morgan Stanley
12
Morgan Stanley
New York
$9K -$6.32K -104 -44%
AG
13
Advisor Group
Arizona
$6K – – –
GWM
14
Geneos Wealth Management
Colorado
$4K -$1.52K -25 -28%
UBS Group
15
UBS Group
Switzerland
$2K – – –
Wells Fargo
16
Wells Fargo
California
$1K – – –
Royal Bank of Canada
17
Royal Bank of Canada
Ontario, Canada
$1K +$182 +3 +60%
BNP Paribas Financial Markets
18
BNP Paribas Financial Markets
France
$5 – – –
VF
19
Virtu Financial
New York
– -$119K -1,914 Closed
BCM
20
Bridgeway Capital Management
Texas
– -$107K -1,720 Closed
WS
21
Wedbush Securities
California
– -$39K -628 Closed
Goldman Sachs
22
Goldman Sachs
New York
– -$17K -267 Closed
Millennium Management
23
Millennium Management
New York
– -$16K -263 Closed
Victory Capital Management
24
Victory Capital Management
Texas
– -$2K -35 Closed

VTVT Hedge Fund Activity: Q4 2019 in Review

18 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in vTv Therapeutics (VTVT) for Q4 2019, worth a combined $1.48M — up 43% from $1.04M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of VTVT and 5 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 2 added.

The largest buyer was Bank of America, adding an estimated $195K. The largest seller was Virtu Financial, exiting entirely with an estimated $119K sold.

  • 18 institutional investors held vTv Therapeutics (VTVT) as of Q4 2019, down from 19 in Q3 2019.
  • Funds reported $1.48M of vTv Therapeutics stock for Q4 2019, up 43% quarter-over-quarter.
  • 5 funds opened new vTv Therapeutics positions in Q4 2019 and 6 closed out, a net change of -1 holder.
  • The largest vTv Therapeutics buyer in Q4 2019 was Bank of America, an estimated $195K added.
  • The largest vTv Therapeutics seller in Q4 2019 was Virtu Financial, an estimated $119K sold.

Based on aggregated 13F filings for Q4 2019.